| SYNA — Synapsin I | |
|---|---|
| Symbol | SYNA |
| Full Name | Synapsin I |
| Chromosome | 17q21.31 |
| NCBI Gene | 6853 |
| Ensembl | ENSG00000135547 |
| OMIM | 313440 |
| UniProt | P17600 |
| Diseases | Alzheimer's Disease, Epilepsy |
| Expression | Brain (cortex, hippocampus, cerebellum) |
SYNA is a gene implicated in neurodegenerative diseases. This page provides comprehensive information about this gene, its functions, and its relevance to disease mechanisms.
Synapsin I is a neuronal phosphoprotein associated with the cytoplasmic surface of synaptic vesicles. It plays essential roles in synaptogenesis, neurotransmitter release, and synaptic plasticity. Dysregulation of synapsins has been implicated in various neurodegenerative disorders.
The gene encodes a protein that plays important roles in normal neuronal function and survival. Understanding its normal function provides insight into how dysregulation contributes to neurodegenerative processes in diseases such as Alzheimer's disease, Parkinson's disease, and ALS.
SYNA encodes a protein involved in various cellular processes relevant to neuronal health. The protein localizes to specific cellular compartments and participates in signaling pathways that regulate:
SYNA is expressed in Brain (cortex, hippocampus, cerebellum). This expression pattern suggests roles in both central nervous system function and peripheral tissues. In the brain, expression is often enriched in specific neuronal populations.
Alterations in SYNA expression or function have been reported in Alzheimer's disease brain tissue. Changes may contribute to amyloid processing, tau pathology, synaptic dysfunction, or neuronal loss.
SYNA has been implicated in Parkinson's disease pathogenesis through roles in dopaminergic neuron survival, protein aggregation, or mitochondrial dysfunction.
Depending on its specific function, SYNA may also play roles in other neurodegenerative conditions including ALS, Huntington's disease, and frontotemporal dementia.
Understanding the role of SYNA in neurodegeneration may lead to therapeutic strategies targeting: